Pfizer Dodges More Sanctions In Neurontin Antitrust MDL
By Bibeka Shrestha · July 7, 2011, 3:44 PM EDT
A magistrate judge refused Tuesday to sanction Pfizer Inc. by striking its denial that it promoted off-label uses of epilepsy drug Neurontin, the latest in a New Jersey multidistrict litigation claiming...
To view the full article, register now.